Moderate resting hypoxaemia is an independent prognostic factor in fibrotic ILD. Potential therapeutic effects of reversing moderate resting hypoxaemia need to be evaluated in this population.https://bit.ly/30PFtoC
No takes yet. Share an insight, caveat, or question.
Khor et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: